Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-06-11Clinical Trial Update: An Open Label Study for Participants With Rheumatoid Arthritis [Phase 3]
This is an open-label Phase 3 trial in rheumatoid arthritis sponsored by Eli Lilly. The study was terminated, and results were posted in 201…
-
CLINICAL_TRIALS trial_result · 2018-06-11Clinical Trial Update: Role of Ultrasound for Evaluating Rheumatoid Arthritis in Remission [NA]
This clinical trial update discusses using ultrasound to evaluate rheumatoid arthritis in patients who are in remission. The study status is…
-
CLINICAL_TRIALS trial_result · 2018-06-07Clinical Trial Update: Personalized Risk Estimator for Rheumatoid Arthritis Family Study [NA]
Clinical trial update describing a personalized risk estimator study for rheumatoid arthritis in first-degree relatives of RA patients; stat…
-
FDA approval · 2018-06-07FDA Approved: ETODOLAC — Original Application (Amneal Pharmaceuticals NY LLC)
The FDA approved the original ANDA for etodolac from Amneal Pharmaceuticals NY LLC, enabling the marketing of a generic etodolac product.
-
CLINICAL_TRIALS trial_result · 2018-06-01Clinical Trial Update: Neuromusuclar Adaptations in the Rheumatoid Arthritis Disease
This update notes the completion of a clinical trial investigating neuromuscular adaptations in rheumatoid arthritis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-05-31FDA Approved: OLUMIANT — Original Application (Eli Lilly and Company)
This FDA page confirms the original approval of Olumiant (baricitinib) by Eli Lilly for rheumatoid arthritis, marking the first FDA approval…
-
CLINICAL_TRIALS trial_result · 2018-05-31Clinical Trial Update: Feasibility of an Immersive Virtual Reality Based Biofeedback Intervention for Outpatients in Rheumatology
This clinical trial update describes a feasibility study of an immersive virtual reality-based biofeedback intervention for outpatients in r…
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: Safety and Efficacy Study of M2951 in Participants With Rheumatoid Arthritis [Phase 2]
A Phase 2 safety and efficacy study of M2951 in rheumatoid arthritis has completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-05-29Clinical Trial Update: Prednisone Timed-Release Tablet (TRT) Study: Modified-Release (MR) Formulation of Prednisone Compared to Standard Immediate-Release (IR) Prednisone in Participants With Rheumatoid Arthritis [Phase 3]
A Phase 3 trial comparing a timed-release prednisone formulation to standard immediate-release prednisone in rheumatoid arthritis has comple…
-
FDA approval · 2018-05-25FDA Approved: ENBREL — Supplemental Application (Immunex Corporation)
FDA approved a supplemental application for ENBREL (etanercept) submitted by Immunex Corporation. The approval pertains to the supplement to…
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: Combination Therapy of F8IL10 and Methotrexate in Rheumatoid Arthritis Patients [Phase 1]
A Phase 1 trial assessing the safety and tolerability of combining F8IL10 with methotrexate in rheumatoid arthritis patients has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Physical Activity Behavior of Rheumatoid Arthritis Patients and Healthy Controls
A completed clinical trial update examining physical activity behavior in rheumatoid arthritis patients and healthy controls.
-
FDA approval · 2018-05-15FDA Approved: HYDROXYCHLOROQUINE SULFATE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved a generic hydroxychloroquine sulfate product from Amneal Pharmaceuticals NY LLC under an original application.
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: A Study in Participants With Rheumatoid Arthritis [Phase 3]
Phase 3 trial in rheumatoid arthritis was terminated, with results posted on 2018-05-14.
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: Long-term Prognosis and Quality of Life in Early Rheumatoid Arthritis Patients Treated by 2015 ACR Guideline (LELAND)
The document provides an update on a clinical trial assessing long-term prognosis and quality of life for patients with early rheumatoid art…
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: BMI and Ultrasound/Clinical Assessments of RA Disease Activity
A completed study evaluating how body mass index and ultrasound/clinical assessments relate to rheumatoid arthritis disease activity.
-
FDA approval · 2018-05-11FDA Approved: ENBREL — Supplemental Application (Immunex Corporation)
The FDA approved a supplemental application for ENBREL (etanercept) submitted by Immunex Corporation. The action updates the drug's labeling…
-
CLINICAL_TRIALS research · 2018-05-11Clinical Trial Update: An Observational Study to Evaluate the Clinical Effectiveness, Quality of Life, Safety and Tolerability of Tocilizumab (TCZ) in Patients With Rheumatoid Arthritis (RA) in Daily Clinical Practice
An observational real-world study evaluating the effectiveness, quality of life, safety, and tolerability of tocilizumab in patients with rh…
-
CLINICAL_TRIALS research · 2018-05-11Clinical Trial Update: U-Act-After: An Observational Study on Long-Term Efficacy of Tight Control RoActemra/Actemra (Tocilizumab) and/or Methotrexate in Patients With Early Rheumatoid Arthritis Who Have Participated in the U-Act-Early Study (ML22497)
An observational study evaluating the long-term efficacy of tight control using tocilizumab and/or methotrexate in patients with early rheum…
-
CLINICAL_TRIALS trial_result · 2018-05-08Clinical Trial Update: Bone Resorption, Osteoclastogenesis and Adalimumab [Phase 4]
Phase 4 clinical trial update evaluating bone resorption and osteoclastogenesis in rheumatoid arthritis patients treated with adalimumab.
-
CLINICAL_TRIALS trial_result · 2018-05-08Clinical Trial Update: RADAR1- Trial of a New Blood Sample Method (Remote Arthritis Disease Activity MonitoR) [NA]
Completed clinical trial RADAR1 evaluating a new blood-sampling method for remote monitoring of rheumatoid arthritis disease activity.
-
CLINICAL_TRIALS trial_result · 2018-05-08Clinical Trial Update: A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate [Phase 3]
A Phase 3 rheumatoid arthritis trial evaluating a Lilly-sponsored agent with background methotrexate was terminated. Results were posted in …
-
FDA approval · 2018-05-08FDA Approved: HYDROXYCHLOROQUINE SULFATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved hydroxychloroquine sulfate as a generic drug under an Original Application (ANDA201691) for Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2018-05-01FDA Approved: HYDROXYCHLOROQUINE SULFATE — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approved the original ANDA for hydroxychloroquine sulfate (generic) from Dr. Reddy's Laboratories Inc. This approval authorizes marketin…
-
CLINICAL_TRIALS research · 2018-05-01Clinical Trial Update: Effect of Periodontal Care on Rhematoid Arthritis in Uganda [NA]
Makerere University is conducting a trial to assess whether periodontal care impacts rheumatoid arthritis outcomes in Uganda.